Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5‐year analysis of the French early access program (EPA)
Guillaume Manson,Charles Herbaux,Jean‐Marc Schiano,Olivier Casasnovas,Aspasia Stamatoullas,Bénédicte Deau,Anna Schmitt,Caroline Regny,Krimo Bouabdallah,Adrien Chauchet,Hervé Ghesquieres,Adrian Tempescul,Remy Dulery,Emmanuelle Nicolas‐Virelizier,Alain Delmer,Cecile Borel,Laurent Dercle,Pauline Brice,Roch Houot British journal of haematology（2022）
AI 理解论文
溯源树
样例
